Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 CAD | +3.03% | 0.00% | -12.82% |
Apr. 25 | Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology | MT |
Apr. 25 | Microbix Collaborator Introduces New Lab Accreditation Program | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.82% | 34.15M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- MBX Stock
- News Microbix Biosystems Inc.
- Microbix Brief: Q4 revenue was $4,264,229, relatively flat from Q4 2022 revenues